Cargando…

Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids

The hepatitis E virus (HEV) is an emerging pathogen showing a considerable increase in the number of reported cases in Europe mainly related to the ingestion of contaminated food. As with other relevant viral foodborne pathogens, real-time reverse transcriptase polymerase chain reaction (RT-qPCR) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Randazzo, Walter, Vasquez-García, Andrea, Aznar, Rosa, Sánchez, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119771/
https://www.ncbi.nlm.nih.gov/pubmed/30210465
http://dx.doi.org/10.3389/fmicb.2018.01973
_version_ 1783352129498382336
author Randazzo, Walter
Vasquez-García, Andrea
Aznar, Rosa
Sánchez, Gloria
author_facet Randazzo, Walter
Vasquez-García, Andrea
Aznar, Rosa
Sánchez, Gloria
author_sort Randazzo, Walter
collection PubMed
description The hepatitis E virus (HEV) is an emerging pathogen showing a considerable increase in the number of reported cases in Europe mainly related to the ingestion of contaminated food. As with other relevant viral foodborne pathogens, real-time reverse transcriptase polymerase chain reaction (RT-qPCR) is the gold standard for HEV detection in clinical, food, and environmental samples, but these procedures cannot discriminate between inactivated and potentially infectious viruses. Thus, the aim of this study was to develop a viability PCR method to discriminate between native, heat-, and high-pressure processing (HPP)-treated HEV using the hepatitis A virus (HAV) as a cultivable surrogate. To this end, different concentrations of viability markers (PMAxx and platinum chloride, PtCl(4)) were screened firstly on purified viral RNA using different RT-qPCR assays. Reductions of HEV RNA signals of >17.5, >15.0, and >15.5 quantification cycles (Cq) were reported for PtCl(4) and 1.6, 2.9, and 8.4 Cq for PMAxx, clearly indicating a better performance of PtCl(4) than PMAxx irrespective of the RT-qPCR assay used. The most efficient viability pretreatment (500 μM PtCl(4) incubated at 5°C for 30 min) was then assessed on native, heat-, and HPP-treated HEV suspension. The optimized viability RT-qPCR discriminated successfully between native, heat-, and HPP-treated HEV, to different extents depending on the experimental conditions. In particular, approximately 2-log(10) reduction was reported by PtCl(4)-RT-qPCR at both 72 and 95°C compared to the control. Additionally, both viability pretreatments were tested for HPP-treated HAV without success, while PtCl(4)-RT-qPCR completely eliminated (>5.6-log(10) reduction) the RT-qPCR signals of HPP-treated HEV. Although this viability procedure may still overestimate infectivity, the PtCl(4) pretreatment represents progress to better interpreting the quantification of intact HEV, and it could be included in molecular procedures used to quantify enteric viruses in food and environmental samples.
format Online
Article
Text
id pubmed-6119771
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61197712018-09-12 Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids Randazzo, Walter Vasquez-García, Andrea Aznar, Rosa Sánchez, Gloria Front Microbiol Microbiology The hepatitis E virus (HEV) is an emerging pathogen showing a considerable increase in the number of reported cases in Europe mainly related to the ingestion of contaminated food. As with other relevant viral foodborne pathogens, real-time reverse transcriptase polymerase chain reaction (RT-qPCR) is the gold standard for HEV detection in clinical, food, and environmental samples, but these procedures cannot discriminate between inactivated and potentially infectious viruses. Thus, the aim of this study was to develop a viability PCR method to discriminate between native, heat-, and high-pressure processing (HPP)-treated HEV using the hepatitis A virus (HAV) as a cultivable surrogate. To this end, different concentrations of viability markers (PMAxx and platinum chloride, PtCl(4)) were screened firstly on purified viral RNA using different RT-qPCR assays. Reductions of HEV RNA signals of >17.5, >15.0, and >15.5 quantification cycles (Cq) were reported for PtCl(4) and 1.6, 2.9, and 8.4 Cq for PMAxx, clearly indicating a better performance of PtCl(4) than PMAxx irrespective of the RT-qPCR assay used. The most efficient viability pretreatment (500 μM PtCl(4) incubated at 5°C for 30 min) was then assessed on native, heat-, and HPP-treated HEV suspension. The optimized viability RT-qPCR discriminated successfully between native, heat-, and HPP-treated HEV, to different extents depending on the experimental conditions. In particular, approximately 2-log(10) reduction was reported by PtCl(4)-RT-qPCR at both 72 and 95°C compared to the control. Additionally, both viability pretreatments were tested for HPP-treated HAV without success, while PtCl(4)-RT-qPCR completely eliminated (>5.6-log(10) reduction) the RT-qPCR signals of HPP-treated HEV. Although this viability procedure may still overestimate infectivity, the PtCl(4) pretreatment represents progress to better interpreting the quantification of intact HEV, and it could be included in molecular procedures used to quantify enteric viruses in food and environmental samples. Frontiers Media S.A. 2018-08-24 /pmc/articles/PMC6119771/ /pubmed/30210465 http://dx.doi.org/10.3389/fmicb.2018.01973 Text en Copyright © 2018 Randazzo, Vasquez-García, Aznar and Sánchez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Randazzo, Walter
Vasquez-García, Andrea
Aznar, Rosa
Sánchez, Gloria
Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
title Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
title_full Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
title_fullStr Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
title_full_unstemmed Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
title_short Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
title_sort viability rt-qpcr to distinguish between hev and hav with intact and altered capsids
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119771/
https://www.ncbi.nlm.nih.gov/pubmed/30210465
http://dx.doi.org/10.3389/fmicb.2018.01973
work_keys_str_mv AT randazzowalter viabilityrtqpcrtodistinguishbetweenhevandhavwithintactandalteredcapsids
AT vasquezgarciaandrea viabilityrtqpcrtodistinguishbetweenhevandhavwithintactandalteredcapsids
AT aznarrosa viabilityrtqpcrtodistinguishbetweenhevandhavwithintactandalteredcapsids
AT sanchezgloria viabilityrtqpcrtodistinguishbetweenhevandhavwithintactandalteredcapsids